The concomitant utilization of oxycodone HCl with all cytochrome P450 3A4 inhibitors may well result in an increase in oxycodone plasma concentrations, which could boost or extend adverse reactions and should cause probably fatal respiratory melancholy. Moreover, discontinuation of the concomitantly